Skip to main content

Table 2 Risk of bias assessment according to the Cochrane collaboration’s risk of bias assessment tool

From: The effect of beinaglutide as an glucagon-like peptide-1 receptor agonists on cardiometabolic factors: a systematic review and meta-analysis

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us